Codes / ICD10CM / T62.0X2S

T62.0X2S Toxic effect of ingested mushrooms, intentional self-harm, sequela

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Toxic effect of ingested mushrooms, intentional self-harm, sequela

Summary

This condition describes residual or late effects resulting from the intentional ingestion of mushrooms containing toxic substances, where the harmful effects persist beyond the active phase of the poisoning. The "sequela" modifier indicates ongoing health consequences related to the initial toxic exposure, which may involve organ damage, neurological impairment, or other chronic complications.

Causes

Sequela arise from the initial toxic effect of ingested mushrooms, where the body’s response to toxins (e.g., amatoxins, muscarine, or psilocybin) leads to lasting damage. Intentional self-harm implies the ingestion was deliberate, and the sequela reflect unresolved or chronic manifestations of the poisoning, such as persistent organ dysfunction or neurological deficits.

Risk Factors

  • Deliberate ingestion of toxic mushrooms for self-harm.
  • Prior exposure to high-toxin mushroom species.
  • Inadequate or delayed initial treatment of the acute poisoning.
  • Underlying health conditions that exacerbate toxin-related damage.

Symptoms

  • Persistent gastrointestinal issues (e.g., chronic pain, malabsorption).
  • Ongoing neurological symptoms (e.g., memory loss, persistent confusion).
  • Chronic liver or kidney dysfunction.
  • Long-term respiratory or cardiovascular instability.
  • Psychological effects related to the self-harm event.

Diagnosis

Diagnosis involves correlating current symptoms with a history of intentional mushroom ingestion and prior toxic effects. Clinical evaluation, including organ function tests and imaging, may be used to assess residual damage. Documentation of the initial poisoning and its sequelae is critical for confirmation.

Treatment Options

Management focuses on addressing chronic complications, such as organ support for persistent dysfunction or rehabilitation for neurological deficits. Treatment plans are tailored to the specific sequelae and may include long-term monitoring, medication, or lifestyle adjustments to manage ongoing symptoms.

Prognosis and Follow-Up

Prognosis depends on the severity of the initial poisoning and the extent of residual damage. Follow-up care is often required to monitor organ function, manage chronic symptoms, and address psychological impacts. Regular assessments help adjust treatment and prevent further deterioration.

Complications

  • Chronic organ failure (e.g., liver cirrhosis, renal insufficiency).
  • Permanent neurological damage (e.g., cognitive impairment).
  • Psychological sequelae (e.g., depression, anxiety related to self-harm).
  • Increased risk of future health issues due to organ damage.

Lifestyle & Prevention

  • Avoid further exposure to toxic mushrooms.
  • Follow medical advice for managing chronic conditions.
  • Engage in mental health support to address self-harm behaviors.
  • Maintain regular health monitoring to detect complications early.

When to Seek Professional Help

Seek care if new or worsening symptoms (e.g., severe pain, confusion, or organ-related issues) emerge, or if psychological distress related to the event persists. Prompt evaluation is essential to address acute exacerbations or new complications.

Tips for Medical Coders

Document the relationship between the initial toxic effect and the sequela clearly, including the intentional self-harm context. Ensure the "sequela" modifier is applied only when the condition represents a residual effect of the poisoning, and verify that the code aligns with the clinical documentation of ongoing symptoms or damage.

Book a walkthrough

T62.0X2S policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.